ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,37%
Bitcoin
66 023,22
-1,10%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AzurRx BioPharma Inc (AZRX)

  7. AzurRx BioPharma Inc (AZRX) Actualités

AZRX

AzurRx BioPharma (AZRX)

AzurRx BioPharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AZRX
DateHeureSourceTitreSymboleSociété
27/06/202323h04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AZRXAzurRx BioPharma Inc
23/06/202322h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
20/06/202322h26Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AZRXAzurRx BioPharma Inc
05/06/202313h01Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:AZRXAzurRx BioPharma Inc
15/05/202323h21Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AZRXAzurRx BioPharma Inc
12/05/202314h33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AZRXAzurRx BioPharma Inc
05/04/202322h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZRXAzurRx BioPharma Inc
04/04/202323h29Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AZRXAzurRx BioPharma Inc
28/03/202312h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AZRXAzurRx BioPharma Inc
23/03/202322h00Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AZRXAzurRx BioPharma Inc
20/03/202321h11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AZRXAzurRx BioPharma Inc
09/01/202315h23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AZRXAzurRx BioPharma Inc
07/12/202222h17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AZRXAzurRx BioPharma Inc
29/11/202200h42Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:AZRXAzurRx BioPharma Inc
11/10/202214h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AZRXAzurRx BioPharma Inc
22/09/202214h56Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:AZRXAzurRx BioPharma Inc
25/07/202223h28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AZRXAzurRx BioPharma Inc
15/07/202222h42Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:AZRXAzurRx BioPharma Inc
17/05/202222h35Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:AZRXAzurRx BioPharma Inc
03/03/202200h02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AZRXAzurRx BioPharma Inc
02/03/202200h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AZRXAzurRx BioPharma Inc
21/09/202118h47GlobeNewswire Inc.AzurRx BioPharma to Change Corporate Name to First Wave BioPharma TodayNASDAQ:AZRXAzurRx BioPharma Inc
14/09/202113h30GlobeNewswire Inc.AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharmaNASDAQ:AZRXAzurRx BioPharma Inc
13/09/202112h00GlobeNewswire Inc.AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease IndicationsNASDAQ:AZRXAzurRx BioPharma Inc
10/09/202118h45GlobeNewswire Inc.AzurRx BioPharma Announces Reverse Stock SplitNASDAQ:AZRXAzurRx BioPharma Inc
10/09/202114h30GlobeNewswire Inc.AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal InfectionsNASDAQ:AZRXAzurRx BioPharma Inc
09/09/202114h30GlobeNewswire Inc.AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal InfectionsNASDAQ:AZRXAzurRx BioPharma Inc
07/09/202122h30GlobeNewswire Inc.AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment ConferenceNASDAQ:AZRXAzurRx BioPharma Inc
18/08/202113h05GlobeNewswire Inc.AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)NASDAQ:AZRXAzurRx BioPharma Inc
17/08/202113h00GlobeNewswire Inc.AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819NASDAQ:AZRXAzurRx BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:AZRX

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
COIN
ETHUSD
Ethereum
EU
VK
Vallourec
NASDAQ
AMZN
Amazon.com
EU
LR
Legrand
EU
BNP
BNP Paribas
EU
PX1
CAC 40
EU
BEL20
Bel 20
EU
RNO
Renault
EU
ACA
Credit Agricole
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
EU
MC
Lvmh Moet Hennessy Louis...
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés